1. Home
  2. ADUS vs NEO Comparison

ADUS vs NEO Comparison

Compare ADUS & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADUS
  • NEO
  • Stock Information
  • Founded
  • ADUS 1979
  • NEO 2001
  • Country
  • ADUS United States
  • NEO United States
  • Employees
  • ADUS N/A
  • NEO N/A
  • Industry
  • ADUS Medical/Nursing Services
  • NEO Precision Instruments
  • Sector
  • ADUS Health Care
  • NEO Health Care
  • Exchange
  • ADUS Nasdaq
  • NEO Nasdaq
  • Market Cap
  • ADUS 2.2B
  • NEO 2.3B
  • IPO Year
  • ADUS 2009
  • NEO 1999
  • Fundamental
  • Price
  • ADUS $131.40
  • NEO $16.53
  • Analyst Decision
  • ADUS Buy
  • NEO Strong Buy
  • Analyst Count
  • ADUS 10
  • NEO 10
  • Target Price
  • ADUS $133.67
  • NEO $20.30
  • AVG Volume (30 Days)
  • ADUS 171.7K
  • NEO 756.1K
  • Earning Date
  • ADUS 11-04-2024
  • NEO 02-18-2025
  • Dividend Yield
  • ADUS N/A
  • NEO N/A
  • EPS Growth
  • ADUS 23.71
  • NEO N/A
  • EPS
  • ADUS 4.37
  • NEO N/A
  • Revenue
  • ADUS $1,133,806,000.00
  • NEO $644,118,000.00
  • Revenue This Year
  • ADUS $10.05
  • NEO $12.98
  • Revenue Next Year
  • ADUS $22.66
  • NEO $9.83
  • P/E Ratio
  • ADUS $30.10
  • NEO N/A
  • Revenue Growth
  • ADUS 10.15
  • NEO 12.06
  • 52 Week Low
  • ADUS $85.94
  • NEO $12.77
  • 52 Week High
  • ADUS $136.12
  • NEO $21.22
  • Technical
  • Relative Strength Index (RSI)
  • ADUS 63.37
  • NEO 44.50
  • Support Level
  • ADUS $126.08
  • NEO $17.24
  • Resistance Level
  • ADUS $131.93
  • NEO $18.20
  • Average True Range (ATR)
  • ADUS 3.46
  • NEO 0.70
  • MACD
  • ADUS 1.23
  • NEO -0.28
  • Stochastic Oscillator
  • ADUS 92.04
  • NEO 6.41

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.

About NEO NeoGenomics Inc.

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

Share on Social Networks: